IceCure Medical (ICCM) Invested Capital (2020 - 2026)

IceCure Medical (ICCM) has reported Invested Capital for 7 consecutive years, with $11.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital rose 140.26% year-over-year to $11.9 million in Q2 2026; TTM through Jun 2026 was $11.9 million, a 140.26% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 28.35% from the prior year.
• Invested Capital was $11.9 million for Q2 2026 at IceCure Medical, up from $8.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $25.9 million in Q4 2022 and troughed at $5.0 million in Q2 2025.
• A 5-year average of $13.5 million and a median of $11.9 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slumped 54.41% in 2025 and surged 140.26% in 2026, its largest moves.
• Over 5 years, Invested Capital stood at $25.9 million in 2022, then sank by 51.5% to $12.5 million in 2023, then sank by 43.68% to $7.1 million in 2024, then climbed by 28.35% to $9.1 million in 2025, then surged by 31.48% to $11.9 million in 2026.
• The last three Invested Capital figures came in at $11.9 million (Q2 2026), $8.5 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.